Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Cannabis sativa CBD Extract Exhibits Synergy with Broad-Spectrum Antibiotics against Salmonella typhimurium

Version 1 : Received: 10 September 2022 / Approved: 12 September 2022 / Online: 12 September 2022 (09:55:22 CEST)

How to cite: Gildea, L.; Ayariga, J.; Xu, J.; Villafane, R.; Boakai, R.; Samuel-Foo, M.; Ajayi, O. Cannabis sativa CBD Extract Exhibits Synergy with Broad-Spectrum Antibiotics against Salmonella typhimurium. Preprints 2022, 2022090143. https://doi.org/10.20944/preprints202209.0143.v1 Gildea, L.; Ayariga, J.; Xu, J.; Villafane, R.; Boakai, R.; Samuel-Foo, M.; Ajayi, O. Cannabis sativa CBD Extract Exhibits Synergy with Broad-Spectrum Antibiotics against Salmonella typhimurium. Preprints 2022, 2022090143. https://doi.org/10.20944/preprints202209.0143.v1

Abstract

New generation antibiotics are needed to combat the development of resistance to antimicrobials. One of the most promising new classes of antibiotics is cannabidiol (CBD). It is a non-toxic and low-resistance chemical that can be used to treat bacterial infections. The antibacterial activity of Cannabis sativa L. byproducts, specifically CBD, has been of growing interest in the field of novel therapeutics. As research continues to define and characterize the antibacterial activity that CBD possesses against a wide variety of bacterial species it is important to examine potential interaction between CBD and common therapeutics such as broad-spectrum antibiotics. Here, we show that CBD-antibiotic co-therapy can effectively fight S. typhimurium via membrane integrity disruption. This research serves to examine the potential synergy between CBD and three broad-spectrum antibiotics for potential antibiotic-CBD co-therapy. In this study, we reveal that Salmonella typhimurium (S. typhimurium) growth is inhibited at very low dosages of CBD-antibiotic. This interesting finding demonstrates that CBD and CBD-antibiotic co-therapies are viable novel alternatives to combating Salmonella typhimurium.

Keywords

Salmonella; novel antibacterial agents; cannabidiol; co-therapy; bacterial genetics

Subject

Biology and Life Sciences, Immunology and Microbiology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.